Semaglutide for the Treatment of Glucose Intolerance in Women With Prior Gestational Diabetes

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 252 participants.

Also called NCT05569772

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 252 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05569772
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Belgium (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05569772. Randomized; triple masking; primary purpose prevention. Start 2023-09-14 (actual); primary completion 2030-03 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Semaglutide for the Treatment of Glucose Intolerance in Women With Prior Gestational Diabetes
Acronym
SERENA
Condition
Glucose Intolerance After a Recent History of Gestational Diabetes
Intervention (Drug)
Semaglutide Pen Injector
Intervention (Drug)
Semaglutide placebo
Lead sponsor
Universitaire Ziekenhuizen KU Leuven (class: other)
Collaborator
University Hospital, Antwerp (class: other)
Collaborator
Universitair Ziekenhuis Brussel (class: other)
Collaborator
General Hospital Groeninge (class: other)
Collaborator
Vitaz (class: other)
Collaborator
Centre Hospitalier Universitaire de Liege (class: other)
Collaborator
Erasme University Hospital (class: other)
Collaborator
Centre Hospitalier Mouscron (class: not stated)
Collaborator
Jan Yperman Ziekenhuis (class: other)
Collaborator
AZ Turnhout (class: other)
Collaborator
AZ Sint-Lucas Brugge (class: other)
Collaborator
Ziekenhuis aan de Stroom (class: other)
Collaborator
Onze Lieve Vrouw Hospital (class: other)

Record details

Record id
cardio:ct-nct05569772
Content hash
78899855f88e2109f3b5b2405b3009af2891925e55a3a46b45c80b75921b63dc